Joel Jose

2 weeks ago | gurutrade.com | Joel Jose |Sumana Nandy

June 9 (Reuters) - Citigroup has pushed back its U.S. rate cut forecast to September from July and now expects three cuts this year instead of four, after a stronger-than-expected May jobs report in an otherwise cooling labor market. The Wall Street brokerage anticipates 75 basis points (bps) of cuts this year in three equal tranches in September, October and December, revising its earlier forecast of 100 bps of cuts.

3 weeks ago | marketscreener.com | Shashwat Chauhan |Joel Jose

Published on 06/04/2025 at 05:35, updated on 06/04/2025 at 10:00 (Reuters) -Shares of Wells Fargo rose more than 2% on Wednesday after the U.S. Federal Reserve lifted a longstanding cap on its assets, marking a crucial milestone in the bank's push to rebuild its reputation and grow further.

1 month ago | today.westlaw.com | Sneha K |Anil D'Silva |Joel Jose

(Reuters) -UnitedHealth Group shares plunged 16% to hit a five-year low on Thursday, after the Wall Street Journal reported that the U.S. Department of Justice was investigating the company for potential Medicare fraud. The latest news adds to the...

1 month ago | marketscreener.com | Sriparna Roy |Joel Jose

(Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's sweeping executive order to slash prescription drug prices would be difficult to implement and face legal challenges. Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines to align with what other countries pay.

1 month ago | sg.finance.yahoo.com | Sriparna Roy |Joel Jose

By Sriparna Roy and Joel Jose (Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's sweeping executive order to slash prescription drug prices would be difficult to implement and face legal challenges. Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines to align with what other countries pay.